Neelkanth Surgicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.40 Cr
- Revenue Growth %
- Ebitda
- Net Worth -1.69%
- Total Assets -21.09%
About Neelkanth Surgicals
Neelkanth Surgicals Private Limited (NSPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 December 2001 and has a history of 23 years and two months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.40 Cr.
Vani Juneja and Varun Juneja serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24236UP2001PTC026382
- Company No.
026382
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Neelkanth Surgicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vani Juneja  | Director | 13-Jun-2022 | Current |
| Varun Juneja | Director | 21-Mar-2022 | Current |
Financial Performance of Neelkanth Surgicals.
Neelkanth Surgicals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Neelkanth Surgicals?
In 2022, Neelkanth Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Blueneck Hospitec LlpVani Juneja and Varun Juneja are mutual person
Charges (Loans)
₹14.00 M
₹0
Charges Breakdown by Lending Institutions
- Andhra Bank : 1.00 Cr
- Union Bank Of India : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Nov 2014 | Andhra Bank | ₹1.00 Cr | Open |
| 29 May 2002 | Union Bank Of India | ₹4.00 M | Open |
How Many Employees Work at Neelkanth Surgicals?
Unlock and access historical data on people associated with Neelkanth Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neelkanth Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neelkanth Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
